title: Should we measure asymmetric dimethylarginine in patients with coronary artery disease?
authors.forename: Jan T
authors.initials: JT
authors.lastname: Kielstein
authors.forename: John P
authors.initials: JP
authors.lastname: Cooke
mesh_terms: D001120:Arginine / Q000031:analogs & derivatives* / Q000097:blood; D015415:Biomarkers / Q000097:blood; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000401:mortality*; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000401:mortality; D006801:Humans; D009026:Mortality; D011237:Predictive Value of Tests; D012307:Risk Factors
chemical_list: D015415:Biomarkers; C018524:N,N-dimethylarginine; D001120:Arginine